Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 2, 1999, Pages 117-120

  Lynch, Gordon S ^a,b   Hinkle, Richard T ^a   Faulkner, John A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clenbuterol; Contractile properties; Force; Power; Skeletal muscle; 2 adrenoceptor agonists

Indexed keywords

CLENBUTEROL;

ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; MALE; MOUSE; MUSCLE CONTRACTION; ORGAN SIZE; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; CLENBUTEROL; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; ORGAN SIZE;

EID: 0033071725     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03001.x     Document Type: Article

References (27)

1. Kim YS, Sainz RD. β-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 1992; 50: 397-407.
2. Carter WJ, Dang AQ, Faas FA, Lynch ME. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats. Metabolism 1991; 40: 855-60.
3. Agbenyega ET, Warcham AC. Effect of clenbuterol on normal and denervated muscle growth and contractility. Muscle Nerve 1990; 13: 199-203.
4. Maltin CA, Hay SM, Delday MI, Smith FG, Lobley GE, Reeds PJ. Clenbuterol, a beta-agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci. Rep. 1987; 7: 525-32.
5. 2-agonist, retards atrophy in denervated muscles. Am. J. Physiol. 1987; 252: E152-5.
6. Delday MI, Maltin CA. Clenbuterol increases the expression of myogenin but not MyoD in immobilized rat muscles. Am. J. Physiol. 1997; 35:E941-4.
7. 2-adrenoceptor activation. Am. J. Physiol. 1992; 26: E50-6.
8. 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am. J. Physiol. 1994; 267: E475-84.
9. Maltin CA, Delday MI, Watson JS et al. Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin. Sci. 1993; 84: 651-4.
10. 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am. J. Physiol. 1994; 267: C865-8.
11. Jones NL, McCartney N, McComas AJ. Human Muscle Power. Human Kinetics Publishers Inc., Champaign, IL. 1986.
12. Dupont-Versteegden EE, Katz MS, McCarter RJ. Beneficial versus adverse effects of long-term use of Clenbuterol in mdx mice. Muscle Nerve 1995; 18: 1447-59.
13. National Institutes of Health. Guide fur the Cure and Use of Laboratory Animals. Office of Science and Health Reports. Public Health Service Publication No. 86-23, Bethesda, MD. 1985.
14. 2-adrenergic agonists on skeletal muscle and adipose tissue. Biochem. J. 1989; 261: 1-10.
15. Hayes A, Williams DA. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin. Exp. Pharm. Physiol. 1994; 21: 757-65.
16. 2-receptor agonist. Am. J. Physiol. 1988; 254: E726-32.
17. 2-agonist administration and exercise on contractile activation of skeletal muscle fibers. J. Appl. Physiol. 1996; 81: 1610-18.
18. Lynch GS, Rafael JA, Hinkle RT et al. Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. Am. J. Physiol. 1997; 272: C2063-8.
19. Brooks SV, Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J. Physiol. 1988; 404: 71-82.
20. Brooks SV, Faulkner JA, McCubbery DA. Power outputs of slow and fast skeletal muscles of mice. J. App. Physiol. 1990; 68: 1282-5.
21. Maltin CA, Delday MI, Reeds PJ. The effect of a growth promoting drug, clenbuterol, on fiber frequency and area in hind limb muscles from young male rats. Biosci. Rep. 1986; 6: 293-9.
22. Torgan CE, Etgen GJ, Kang HY, Ivy JL. Fiber type-specific effects of clenbuterol and exercise training on insulin-resistant muscle. J. Appl. Physiol. 1995; 79: 163-7.
23. Dodd SL, Powers SK, Vrabas I, Criswell D, Stetson S, Hussain R. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle. Med. Sci. Sports Exer. 1996; 28: 669-76.
24. Murphy RJL, Béliveau L, Seburn KL, Gardiner PF. Clenbuterol has a greater influence on untrained than on previously trained skeletal muscle in rats. Eur. J. Appl. Physiol. 1996; 73: 304-10.
25. MacLennan PA, Edwards RHT. Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle β-adrenoceptors to induce hypertrophy. Biochem. J. 1989; 264: 573-9.
26. Prather ID, Brown DE, North P, Wilson JR. Clenbuterol: A substitute for anabolic steroids. Med. Sci. Sports Exerc. 1995; 27: 1118-21.
27. Hill AV. The dimensions of animals and their muscular dynamics. Proc. R. Inst. Gt Br. 1950; 34: 450-71.